Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer.

Mitsuyoshi TeiShingo NouraMasayuki OhueMasatoshi KitakazeHidekazu TakahashiNorikatsu MiyoshiMamoru UemuraTsunekazu MizushimaKohei MurataYuichiro DokiHidetoshi Eguchi

Published in: International journal of clinical oncology (2021)

CRT with S-1 after limited surgery for T1 or T2 lower rectal cancer resulted in a low incidence of toxicities and maintenance of anal function.

Keyphrases

rectal cancer
locally advanced
minimally invasive
coronary artery bypass
surgical site infection
early stage
risk factors
open label
squamous cell carcinoma
clinical trial
randomized controlled trial
heart failure
radiation therapy
acute coronary syndrome